We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Department has issued guidance on the use of the prescribing Better Care Better Value Indicators, especially in relation to the indicator for statins.
Methodology note and reporting template for the Defra international indicator 1b.
Information relating to good clinical practice (GCP) inspections.
How to use a cost effectiveness analysis to evaluate your digital health product.
Preventing people in England from developing high blood pressure (hypertension), and detecting and managing it better in those who have it.
The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of episodes of severe hypertension.
Information on how ICH E6(R3) good clinical practice (GCP) principles are implemented and enforced in UK clinical trial legislation.
Guidance on good manufacturing practice and the use of radiopharmaceutical investigational medicinal products in clinical trials.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).